27.07.2012
- Merck & Co reported better-than-expected quarterly earnings on strong sales of vaccines and treatments for diabetes and HIV, giving investors greater faith the company can weather...
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
19.07.2012
- Swiss drugmaker Novartis posted a smaller than expected fall in second-quarter core earnings and said tight cost control and strong sales of new drugs would help it cope with a...
12.07.2012
- Annual global spending on prescription drugs will rise 25% by 2016 to $1.2 trillion, as surging growth in emerging markets eclipses weak gains in developed markets like the United...
24.06.2012
- Teva Pharmaceutical Industries rose more than 11% on Sunday after a U.S. court upheld Teva's patents for multiple sclerosis drug Copaxone well into 2015. Israel-based Teva, the...
08.06.2012
- According to a new Espicom report, The World Generic Market Report, the global markets for generic drugs will continue to grow despite cost containment pressures from health payers...
06.06.2012
- Pfizer will cut 177 jobs in Ireland following the expiration of patents on blockbuster cholesterol drug Lipitor, highlighting the exposure of Ireland's export-driven economy to the...
01.06.2012
- AstraZeneca's new chairman took the helm on Friday and said the troubled drugmaker faced "a period of significant change". Leif Johansson's first priority is to find a permanent...
